Long-Acting Injectables at Substance Use Disorders: A Comprehensive Review and Update 2027
2 sessions on long-acting injectables · February 15–17, 2027, Lake Buena Vista, FL. Compare long-acting injectables at other meetings →
Monday, February 15
12:50–13:20 · Lecture · Module Topic 4: Opioids
Long-Acting Injectable Buprenorphine
Covers long-acting injectable buprenorphine formulations.
13:20–13:40 · Lecture · Module Topic 4: Opioids
Naltrexone Intramuscular
Discusses intramuscular naltrexone in treatment.
Other topics at this meeting
Substance Use Disorders 24Opioid Use Disorder 5Alcohol Use Disorder 4Cannabis & Cannabinoids 3Psychotherapy 3Child & Adolescent 2Perinatal & Women's Mental Health 2PTSD & Trauma 2ADHD 1Anxiety Disorders 1Benzodiazepines & Sedatives 1Collaborative & Integrated Care 1